Tokyo Tape
Sign in
← Otsuka Holdings

Quarterly report · Q3

4578.TEDINET S100PGE4
Period2022-01-01 → 2022-09-30
Filed2022-11-02
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥1.27T2022-01-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥451.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥1.50T2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.11T2021-01-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥388.6bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥114.8bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥47.7bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥158.1bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥47.0bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥146.0bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥53.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥163.6bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥166.3bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.1bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥111.0bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.3bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥125.5bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥126.6bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥113.9bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.4bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥130.0bn2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥36.3bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥3.19Tat 2022-09-30Cons.Assets IFRS
Total assets¥2.82Tat 2021-12-31Cons.Assets IFRS
Total assets¥2.82Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥853.3bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥775.7bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥2.33Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥2.05Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥2.02Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.88Tat 2020-12-31dCons.Equity IFRS
Equity (owners)¥2.30Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.01Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.98Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥477.3bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥410.7bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥448.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥356.9bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥171.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥228.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥197.2bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥60.4bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥95.3bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥33.0bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥84.0bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥95.8bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥83.7bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥204.652022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥76.062022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥231.322021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥233.52021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥64.972021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥204.632022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥76.042022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥231.152021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥233.342021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥64.82021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio72.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.5%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 88
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-09-30¥126.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-07-01 → 2022-09-30¥43.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-09-30¥94.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-07-01 → 2022-09-30¥31.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-09-30¥31.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-07-01 → 2022-09-30¥11.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30¥2.0bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥34.8bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥12.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥12m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-01-01 → 2022-09-30¥5.6bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-07-01 → 2022-09-30¥3.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥7m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥49.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥21.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥84.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥32.3bn
—segment totalrevenue2022-01-01 → 2022-09-30¥1.30T
—segment totalrevenue2022-07-01 → 2022-09-30¥463.7bn
—segment totalrevenue external2022-01-01 → 2022-09-30¥1.27T
—segment totalrevenue external2022-07-01 → 2022-09-30¥451.8bn
—segment totalrevenue intersegment2022-01-01 → 2022-09-30¥32.0bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥11.9bn
—segment totalsegment profit2022-01-01 → 2022-09-30¥149.7bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥59.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-01-01 → 2021-09-30¥110.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-07-01 → 2021-09-30¥36.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-01-01 → 2021-09-30¥82.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-07-01 → 2021-09-30¥26.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-01-01 → 2021-09-30¥28.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-07-01 → 2021-09-30¥10.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-01-01 → 2021-09-30¥12.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-07-01 → 2021-09-30¥2.8bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-09-30−¥28.5bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-09-30−¥28.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥10.4bn
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-09-30−¥33.6bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥11.8bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2021-01-01 → 2021-09-30¥24.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2021-07-01 → 2021-09-30¥8.9bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2021-01-01 → 2021-09-30¥24.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2021-07-01 → 2021-09-30¥8.9bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥17m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥8m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2021-01-01 → 2021-09-30¥5.8bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2021-07-01 → 2021-09-30¥2.5bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2021-01-01 → 2021-09-30¥280.1bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2021-07-01 → 2021-09-30¥104.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2021-01-01 → 2021-09-30¥280.0bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2021-07-01 → 2021-09-30¥104.7bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2021-01-01 → 2021-09-30¥33m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥12m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2021-01-01 → 2021-09-30¥45.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2021-07-01 → 2021-09-30¥19.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2021-01-01 → 2021-09-30¥721.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2021-07-01 → 2021-09-30¥248.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2021-01-01 → 2021-09-30¥721.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2021-07-01 → 2021-09-30¥248.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2021-01-01 → 2021-09-30¥128.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2021-07-01 → 2021-09-30¥34.5bn
—segment totalrevenue2021-01-01 → 2021-09-30¥1.14T
—segment totalrevenue2021-07-01 → 2021-09-30¥399.0bn
—segment totalrevenue external2021-01-01 → 2021-09-30¥1.11T
—segment totalrevenue external2021-07-01 → 2021-09-30¥388.6bn
—segment totalrevenue intersegment2021-01-01 → 2021-09-30¥28.5bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥10.4bn
—segment totalsegment profit2021-01-01 → 2021-09-30¥191.8bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥58.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 835
ItemContextValueUnit
Liabilities IFRSCurrentQuarterInstant853317000000JPY
Share capital IFRSPrior1YearInstant81690000000JPY
Share capital IFRSCurrentQuarterInstant81690000000JPY
Capital surplus IFRSPrior1YearInstant506724000000JPY
Capital surplus IFRSCurrentQuarterInstant506470000000JPY
Treasury shares IFRSPrior1YearInstant-45572000000JPY
Treasury shares IFRSCurrentQuarterInstant-44858000000JPY
Retained earnings IFRSPrior1YearInstant1482197000000JPY
Retained earnings IFRSCurrentQuarterInstant1540397000000JPY
Other components of equity IFRSPrior1YearInstant-14046000000JPY
Other components of equity IFRSCurrentQuarterInstant213227000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant2010994000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant2296927000000JPY
Non controlling interests IFRSPrior1YearInstant34195000000JPY
Non controlling interests IFRSCurrentQuarterInstant37493000000JPY
Equity IFRSPrior1YearInstant2045189000000JPY
Equity IFRSCurrentQuarterInstant2334421000000JPY
Liabilities and equity IFRSPrior1YearInstant2820915000000JPY
Liabilities and equity IFRSCurrentQuarterInstant3187738000000JPY
Revenue IFRSPrior1YTDDuration1107417000000JPY
Revenue IFRSCurrentYTDDuration1266119000000JPY
Cost of sales IFRSPrior1YTDDuration358668000000JPY
Cost of sales IFRSCurrentYTDDuration427016000000JPY
Gross profit IFRSPrior1YTDDuration748749000000JPY
Gross profit IFRSCurrentYTDDuration839103000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration439009000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration523338000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration8644000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration3696000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration162521000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration193765000000JPY
Impairment losses pl IFRSPrior1YTDDuration5051000000JPY
Impairment losses pl IFRSCurrentYTDDuration30697000000JPY
Other income IFRSPrior1YTDDuration10571000000JPY
Other income IFRSCurrentYTDDuration20812000000JPY
Other expenses IFRSPrior1YTDDuration3252000000JPY
Other expenses IFRSCurrentYTDDuration961000000JPY
Operating profit loss IFRSPrior1YTDDuration158130000000JPY
Operating profit loss IFRSCurrentYTDDuration114848000000JPY
Finance income IFRSPrior1YTDDuration11056000000JPY
Finance income IFRSCurrentYTDDuration35177000000JPY
Finance costs IFRSPrior1YTDDuration2878000000JPY
Finance costs IFRSCurrentYTDDuration4026000000JPY
Profit loss before tax IFRSPrior1YTDDuration166308000000JPY
Profit loss before tax IFRSCurrentYTDDuration145999000000JPY
Income tax expense IFRSPrior1YTDDuration36275000000JPY
Income tax expense IFRSCurrentYTDDuration32053000000JPY
Profit loss IFRSPrior1YTDDuration130033000000JPY
Profit loss IFRSCurrentYTDDuration113945000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration126648000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass